Main Content
CV of Prof. Dr. Markus A. Ruegg
| ORCID | 0000-0002-4974-9384 |
| Nationality: | Swiss |
| Positions: | |
| Since 2021 – | Co-founder and CEO of SEAL Therapeutics Ltd. Weblink |
| Since 2004 – | Full Professor of Neurobiology |
| 1998 – 2004 | Associate Professor of Neurobiology |
| 1992 – 1997 | Assistant Professor |
| 1989 – 1992 | Postdoctoral Fellow, Department of Neurobiology, Stanford University School of Medicine |
| Education: | |
| 1985 – 1988 | Graduate Studies in Biochemistry and Neurobiology, Institute of Biochemistry University of Zurich |
| 1979 – 1985 | Studies of Biochemistry at the University of Zurich |
| 1975 – 1979 | Kantonsschule Aarau, Aarau, Switzerland, Matura Typus B |
| Selected Awards & Honors: | |
| 2021 | Lelio Orci Award from Life Sciences Switzerland |
| 2000 | Robert Bing Prize from the Swiss Academy of Medical Sciences |
| 1989 | Faculty of Sciences of the University of Zürich: Distinction for Ph.D. thesis |
| Selected Memberships: | |
| Since 2021 – | Vice-President of the Swiss Foundation for Research and Muscle Diseases (FSRMM) |
| Since 2021 – | President of the Animal Ethics Commission of the Kantons of Basel-Stadt, Basel-Landschaft and Aargau. |
| Since 2020 – | Co-Editor in Chief Skeletal Muscle |
| Since 2020 – | Editorial Board of “Current Research in Physiology” |
| Since 2017 – | Section head of Musculoskeletal Pharmacology of “Faculty1000Prime” |
| Since 2017 – | Editorial Board of “Current Opinion in Physiology” |
| Since 2014 – | Associate Editor of "Journal of Neuromuscular Diseases" |
| 2014 – 2020 | Member of the ENMC research committee |
| Since 2013 – | Chairman of the Scientific Advisory Committee of the Swiss Foundation for Research and Muscle Diseases (FSRMM) |
| 2012 – 2018 | Member of the Medical Research Committee of “Muscular Dystrophy Campaign” UK |
| Since 2009 – | Scientific and Medical Advisory Board of "Cure CMD" |
| 2000 – 2007 | Council member of the Swiss Society for Neuroscience |
